Investor FAQ

1. What does Quidel do?

Quidel Corporation is a leader in developing, manufacturing and marketing point-of-care (POC) diagnostic tests for the detection and management of a variety of medical conditions and illnesses. In the U.S., we are a market leader in several POC product categories for sale to hospitals, reference labs, and physician offices.

2. When was the Company founded?

Quidel Corporation was founded in 1979.

3. Where is the Company headquarters?

The Company’s corporate office is located at 12544 High Bluff Drive, Suite 200, San Diego, CA 92130, USA.

4. When did Quidel become a publicly traded company?

In January of 1991, in connection with its merger with Monoclonal Antibodies, Inc., the surviving company was named Quidel Corporation, (Nasdaq: QDEL), a Delaware corporation.

5. Does Quidel have operations outside the United States?

Quidel has commercial offices and a research and manufacturing facility in Germany. In addition, we market our products internationally through medical distributors and sales agents in Asia Pacific, Europe, the Middle East, Africa, Canada, and Latin America.

6. How many people does Quidel employ?

As of May 6, 2015, we have approximately 615 employees worldwide.

7. Who are Quidel’s executive officers and directors?

This information can be found in the “Corporate Governance” section of our website.

8. Who is the Independent Auditors for Quidel?

Ernst & Young LLP
4370 La Jolla Village Drive, Suite 500
San Diego, CA 92101

9. Who are Quidel’s Stock Transfer Agent and Registrar?

American Stock Transfer & Trust Company
59 Maiden Lane
Plaza Level
New York, NY 10038
(800) 937-5449

10. How can I receive information about Quidel?

Go to the “Information Request” page of our website and complete the form provided to request the information you would like to receive.